Pair-wise comparison analysis was performed initially for 20 primary infant NB tumours diagnosed at < 12 months; owing to the small number of cases, stage 4 NB were analyzed together without distinction of MYCN gene status (8 stage 4s and 12 infant stage 4, including 5 MYCN amplified cases). The gene discussed is MYCN; the disease is neuroblastoma.